What Has Been the Growth of the Wildlife Health Market So Far?
The wildlife health market has seen considerable growth due to a variety of factors.
•The dimensions of the wildlife health market have been expanding speedily in the past few years. The projection is that it will escalate from $2.49 billion in 2024 to reach $2.75 billion in 2025, presenting a compound annual growth rate (CAGR) of 10.3%.
Reasons for the progress during the past years include habitat loss, accessibility of health care facilities for wild animals, innovative medical delivery techniques for the animals in safe havens or zoos, along with an increase in governmental actions to curb zoonotic diseases originating from wildlife reservoirs.
What Are the Future Growth Projections for the Wildlife Health Market?
The wildlife health market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the wildlife health market is predicted to undergo swift expansion in the years to come. The sector is projected to balloon to a value of $4.08 billion by 2029, with a compound annual growth rate (CAGR) of 10.4%.
This predicted increase during the forecast period is due to a rising demand for a diverse range of animal health items, regional potential, a surge in the demand for companion animal health products, and tactical actions taken by industry titans. Also increasing the demand for veterinary software. Noteworthy trends for the forecast period encompass global cooperation in monitoring diseases, the application of data analytics, and artificial intelligence, an uptick in wildlife preservation efforts, programs and sources of funding.
Which Factors Are Boosting Growth In The Wildlife Health Market?
The wildlife health market's expansion is projected to be fueled by a rise in zoonotic disease prevalence. Zoonotic diseases, which are infections or illnesses that can naturally spread between animals and humans or vice versa, will encourage the improvement and production of various health products aimed at wildlife. For instance, the European Food Safety Authority (EFSA), a government agency based in Italy, reported in December 2023 that the two most prevalent zoonoses in humans in 2022 were campylobacteriosis and salmonellosis, with 137,107 and 65,208 cases, respectively. While there was a minor decrease of 210 cases in Campylobacteriosis, Salmonellosis had an increment of 5,039 cases. Nonetheless, the prevalence rates per 100,000 population remained steady at 43.1 for campylobacteriosis and 15.3 for salmonellosis, mirroring the 2021 figures. As a result, the rise in zoonotic disease prevalence is pushing the growth of the wildlife health market forward.
What Key Areas Define The Segmentation Of The Global Wildlife Health Market?
The wildlife health market covered in this report is segmented –
1) By Animal Type: Mammals, Birds, Fish, Reptiles, Amphibians
2) By Product: Medicine, Equipment And Consumables
3) By Route Of Administration: Oral, Injectable, Other Routes Of Administration
4) By End-User: Zoos, Wildlife Sanctuaries, Wildlife Rescue And Rehab Centers, Other End Users
Subsegments:
1) By Mammals: Large Mammals, Small Mammals
2) By Birds: Raptors, Waterfowl, Songbirds
3) By Fish: Freshwater Fish, Saltwater Fish
4) By Reptiles: Snakes, Lizards, Turtles And Tortoises
5) By Amphibians: Frogs, Salamanders, Newts
Pre-Book The Wildlife Health Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Wildlife Health Market?
Growing technological innovation is an influential trend within the wildlife health market. Notable organizations involved in this market are embracing new technological advances to solidify their roles within the industry. In the year 2023, the United States Department of Agriculture (USDA), a federal entity, began applying new testing procedures to identify and trace COVID variants in both wild and house pets. These strategies assist in controlling the distribution of zoonotic diseases. Currently, the USDA's Animal and Plant Health Inspection Service (APHIS) is using a $300 million allotment from the American Rescue Plan Act to oversee and track animals susceptible to the COVID virus. Through this effort, the Agricultural Research Service (ARS) is collaborating with APHIS, undertaking five study initiatives aimed at deepening their understanding of the virus and supporting APHIS in its objective to establish an early detection system to potentially stop or minimize the impact of future zoonotic disease outbreaks or global pandemics.
Who Are the Key Players in the Wildlife Health Market?
Major companies operating in the wildlife health market include:
• Bayer AG
• Novartis AG
• Merck & Co Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• IDEXX Laboratories Inc.
• Génia USA Inc.
• Orion Corporation
• Virbac Group
• Royal Canin
• Ceva Santé Animale Group
• Phibro Animal Health Corporation
• Dechra Pharmaceuticals PLC
• Huvepharma
• Vétoquinol
• Indian Immunologicals Limited
• Norbrook Laboratories Limited
• Heska Corporation
• Biogenesis Bago
• Animalcare Group plc
• Pneu-Dart Inc.
• PetAg Inc.
What Is The Most Dominant Region In The Wildlife Health Market?
North America was the largest region in the wildlife health market in 2024. The regions covered in the wildlife health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
